Abstract
Most compounds involved in the metabolism of cells, organs and organisms are hydrophilic in nature, possessing polar groups capable of undergoing a variety of metabolic reactions. Lipophilic molecules, like steroids or the fat-soluble vitamins, are in the minority. These latter compounds consist, in substantial part, of aromatic or alicyclic rings and/or aliphatic side-chains. These hydrocarbon groups are metabolically rather inert and in fact only one group of enzymes, the mono-oxygenases, can attack aromatic or aliphatic C—H bonds. Monooxygenases use molecular oxygen and two electrons from an external donor to introduce an oxygen atom into organic substrates according to the equation (Mason, 1957):
where RH represents substrate and DH2 represents reduced electron donor. Such enzymes play an important role in the formation and transformation of steroids, bile acids, amino acids or vitamins (Ullrich, 1972). Micro-organisms using lipophilic compounds as the sole carbon source rely on the presence of mono-oxygenases for the initial oxidation of the substrate to alcohols, which can be further oxidised with concomitant production of chemical energy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alvares, A. P., Leigh, S., Kappas, A., Levin, W. and Conney, A. H. (1973). Drug Metab. Disposition, 1, 386
Brodie, B. B., Gillette, J. R. and LaDu, B. N. (1958). Ann. Rev. Biochem., 27, 427
Conney, A. H., Levin, W., Jacobson, M., Kuntzman, R., Cooper, D. Y. and Rosenthal, O. (1969). Microsomes and Drug Oxidations (ed. Gillette, Conney, Cosmides, Estabrook, Fouts and Mannering), Academic Press, New York, p. 279
Diehl, H., Schädelin, J. and Ullrich, V. (1970). Hoppe-Seyler’s Z. Physiol. Chem., 351, 1359
Estabrook, R. W., Cooper, D. Y. and Rosenthal, O. (1963). Biochem. Z., 338, 741
Estabrook, R. W., Hildebrandt, A. G., Baron, J., Netter, K. J. and Leibman, K. (1971). Biochem. Biophys. Res. Commun., 42, 132
Frommer, U. and Ullrich, V. (1971). Z. Naturforschg., 26b, 322
Frommer, U., Ullrich, V. and Staudinger, Hj. (1970). Hoppe -Seyler’s Z. Physiol. Chem., 351, 903
Frommer, U., Ullrich, V., Staudinger, Hj. and Orrenius, S. (1972). Biochem. Biophys. Acta, 280, 487
Gigon, P. L., Gram, T. E. and Gillette, J. R. (1969). Molec. Pharmacol., 5, 109
Griffin, B. W. and Peterson, J. A. (1975). J. Biol. Chem., 250, 6445
Gunsalus, I. C. (1970). Conference on cytochrome P450, Philadelphia
Haugen, D. A., van der Hoeven, T. A. and Coon, M. J. (1975). J. Biol. Chem., 250, 3567
Hrycay, E., Gustafsson, J. A., Ingelmann-Sundberg, M. and Ernster, L. (1975). Biochem. Biophys. Res. Commun., 66, 357
Ishimura, Y., Ullrich, V. and Peterson, J. A. (1971). Biochem. Biophys. Res. Commun., 42, 140
Iyanagi, T. and Mason, H. S. (1973). Biochemistry, 12, 2297
Jerina, D., Daly, J. W., Landis, W., Witkop, B. and Udenfriend, S. (1968). J. Amer. Chem. Soc., 90, 6523
Koch, St., Tang, S. C., Holm, R. H., Frankel, R. B. and Ibers, J. A. (1975). J. Amer. Chem. Soc., 97, 916
Kuntzman, R. (1969). Ann. Rev. Pharmacol., 9, 21
Lehrmann, Ch., Ullrich, V. and Rummel, W. (1973). Naunyn-Schmiedeberg’s Arch. Pharmacol., 276, 89
Lichtenberger, F., Nastainczyk, W. and Ullrich, V. Biochem. Biophys. Res. Commun., 70, 939
Lu, A. Y. H., Junk, K. W. and Coon, M. J. (1969). J. Biol. Chem., 244, 3714
Mannering, G. J., Kuwahara, S. and Omura, T. (1974). Biochem. Biophys. Res. Commun., 57, 476
Mason, H. S. (1957). Adv. Enzymol., 19, 79
Morimoto, T., Matsuura, S., Sasaki, S., Tashiro, Y. and Omura, T. (1976). J. Cell. Biol., 68, 189
Omura, T. and Sato, R. (1964). J. Biol. Chem. 239, 2370
Pedersen, M. G., Hershberger, W. K. and Juchau, M. R. (1974). Bull. Environment. Contam. Toxicol., 12, 481
Peisach, J. and Blumberg, W. E. (1970). Proc. Nat. Acad. Sci. USA, 67, 172
Rahimtula, A. D. and O’Brien, P. J. (1974). Biochem. Biophys. Res. Commun., 60, 440
Remmer, H., Schenkman, J. B., Estabrook, R. W., Sasame, H. A., Gillette, J. R., Cooper, D. Y., Narasimhulu, S. and Rosenthal, O. (1966). Molec. Pharmacol., 2, 187
Schenkman, J. B., Remmer, H. and Estabrook, R. W. (1967). Molec. Pharmacol., 3, 113
Staudt, H., Lichtenberger, F. and Ullrich, V. (1974). Eur. J. Biochem. 46, 99
Strobel, H. W., Lu, A. Y. H., Heidema, J. and Coon, M. J. (1970). J. Biol. Chem., 245, 4851
Ullrich, V. (1968). Hoppe-Seyler’sZ. Physiol. Chem., 350, 357
Ullrich, V. (1972). Angew. Chem. (Int. Ed.). 11, 701
Ullrich, V. and Staudinger, Hj. (1968). Biochemie des Sauerstoffs (ed. Hj. Staudinger and B. Hess), Springer, Berlin
Ullrich, V. and Weber P. (1972). Hoppe -Seyler’s Z. Physiol. Chem., 353, 1171
Ullrich, V., Weber, P. and Wollenberg, P. (1975). Biochem. Biophys. Res. Commun., 64, 808
Ullrich, V., Wolf, J., Amadori, E. and Staudinger, Hj. (1967). Hoppe-Seyler’s Z. Physiol. Chem., 349, 85
Waterfall, J. F. and Sims, P. (1973). Biochem. Pharmacol., 22, 2469
Waterman, M. R. and Mason, M. S. (1970). Biochem. Biophys. Res. Commun., 39, 450
Waterman, M. R., Ullrich, V. and Estabrook, R. W. (1973). Arch. Biochem. Biophys., 155, 355
Wattenberg, L. W. and Leong, J. L. (1965). Fed. Proc., 24, 494
Wattenberg, L. W., Leong, J. L. and Strand, P. J. (1962). Cancer Res., 22, 1120
Welton, A. F. and Aust, S. D. (1974). Biochem. Biophys. Res. Commun., 56, 898
Wilson, G. S., Tsibris, J. C. M. and Gunsalus, I. C. (1973). J. Biol. Chem., 248, 6059
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Copyright information
© 1977 Institute of Biology Endowment Trust Fund
About this chapter
Cite this chapter
Ullrich, V. (1977). The mechanism of cytochrome P450-catalysed drug oxidations. In: Roberts, G.C.K. (eds) Drug Action at the Molecular Level. Biological Council. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-03230-3_11
Download citation
DOI: https://doi.org/10.1007/978-1-349-03230-3_11
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-03232-7
Online ISBN: 978-1-349-03230-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)